Literature DB >> 9893055

Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation.

M N Ajuebor1, L Virág, R J Flower, M Perretti, C Szabó.   

Abstract

In the present study, by comparing the responses in wild-type mice and mice lacking the inducible (or type 2) nitric oxide synthase (iNOS), we investigated the role played by iNOS in the regulation of polymorphonuclear granulocyte (PMN) accumulation and chemokine production in the mouse peritoneal cavity in response to administration of zymosan (0.2 mg). Zymosan injection induced the production of nitric oxide, and triggered a time-dependent PMN immigration into the peritoneal cavity. This response was associated with increases in the level of the chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-2, monocyte chemo-attractant protein (MCP)-1 and cytokine-induced neutrophil chemo-attractant (KC), as measured in the peritoneal cavities. Injection of zymosan also induced a time-dependent increase in the production of the anti-inflammatory cytokine interleukin-10 (IL-10) in the peritoneal cavity. When comparing the response between wild-type and iNOS knockout (KO) mice, we observed that the low-level PMN accumulation measured at 1 hr was slightly but significantly increased in the absence of functional iNOS. On the other hand, the delayed response (2-4 hr after zymosan) of PMN accumulation was suppressed in the iNOS KO mice. The early enhancement of PMN infiltration in the iNOS-deficient mice was associated with increased peritoneal levels of MIP-2, KC and IL-10 proteins. The delayed suppression of PMN infiltration was associated with reduced MIP-2 and IL-10 levels in the peritoneal cavity. The lack of iNOS did not affect the release of MIP-1alpha and MCP-1 at any of the time-points studied. The current data demonstrate that iNOS regulates the production of certain CXC (but not CC) proinflammatory chemokines, the production of IL-10 and exerts a biphasic regulatory effect on PMN accumulation in zymosan-induced acute inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893055      PMCID: PMC1364362          DOI: 10.1046/j.1365-2567.1998.00644.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

1.  Role of induced nitric oxide synthase and increased NO levels in zymosan peritonitis in the rat.

Authors:  N K Boughton-Smith; A Ghelani
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

Review 2.  Properties and functions of interleukin-10.

Authors:  T R Mosmann
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

3.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.

Authors:  V E Laubach; E G Shesely; O Smithies; P A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

4.  Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart.

Authors:  L M Villa; E Salas; V M Darley-Usmar; M W Radomski; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells.

Authors:  A M Zeiher; B Fisslthaler; B Schray-Utz; R Busse
Journal:  Circ Res       Date:  1995-06       Impact factor: 17.367

Review 6.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

7.  Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse.

Authors:  M Perretti; C Szabó; C Thiemermann
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

Authors:  J D MacMicking; C Nathan; G Hom; N Chartrain; D S Fletcher; M Trumbauer; K Stevens; Q W Xie; K Sokol; N Hutchinson
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

9.  Altered immune responses in mice lacking inducible nitric oxide synthase.

Authors:  X Q Wei; I G Charles; A Smith; J Ure; G J Feng; F P Huang; D Xu; W Muller; S Moncada; F Y Liew
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

10.  Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.

Authors:  M A Cassatella; L Meda; S Bonora; M Ceska; G Constantin
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  24 in total

1.  Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages.

Authors:  Yu-Xi Yan; Mei-Juan Shao; Qing Qi; Yan-Sheng Xu; Xiao-Qian Yang; Feng-Hua Zhu; Shi-Jun He; Pei-Lan He; Chun-Lan Feng; Yan-Wei Wu; Heng Li; Wei Tang; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2018-05-31       Impact factor: 6.150

2.  The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties.

Authors:  Trinidad Montero-Melendez; Hetal B Patel; Michael Seed; Søren Nielsen; Thomas E N Jonassen; Mauro Perretti
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

Review 3.  Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis.

Authors:  Cindy L H Yang; Terry C T Or; Marco H K Ho; Allan S Y Lau
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

Review 4.  Herbal medicinal products target defined biochemical and molecular mediators of inflammatory autoimmune arthritis.

Authors:  Shivaprasad H Venkatesha; Brian M Berman; Kamal D Moudgil
Journal:  Bioorg Med Chem       Date:  2010-10-31       Impact factor: 3.641

5.  ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration.

Authors:  Roberta Martinelli; Matthew Gegg; Rebecca Longbottom; Peter Adamson; Patric Turowski; John Greenwood
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

Review 6.  Nitric Oxide Therapy for Diabetic Wound Healing.

Authors:  Maggie J Malone-Povolny; Sara E Maloney; Mark H Schoenfisch
Journal:  Adv Healthc Mater       Date:  2019-01-15       Impact factor: 9.933

7.  Involvement of nitric oxide in a rat model of carrageenin-induced pleurisy.

Authors:  Masahiro Iwata; Shigeyuki Suzuki; Yuji Asai; Takayuki Inoue; Kenji Takagi
Journal:  Mediators Inflamm       Date:  2010-06-02       Impact factor: 4.711

8.  Protein nitration in cutaneous inflammation in the rat: essential role of inducible nitric oxide synthase and polymorphonuclear leukocytes.

Authors:  S A B Greenacre; F A C Rocha; A Rawlingson; S Meinerikandathevan; R N Poston; E Ruiz; B Halliwell; S D Brain
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

9.  Regulatory effects of iNOS on acute lung inflammatory responses in mice.

Authors:  Cecilia L Speyer; Thomas A Neff; Roscoe L Warner; Ren-Feng Guo; J Vidya Sarma; Niels C Riedemann; Megan E Murphy; Hedwig S Murphy; Peter A Ward
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

10.  Effects of nitric oxide on neutrophil influx depends on the tissue: role of leukotriene B4 and adhesion molecules.

Authors:  A C R M Leite; F Q Cunha; D Dal-Secco; S Y Fukada; V C C Girão; F A C Rocha
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.